Jean Bennett (Brent N. Clarke/Invision/AP Images)
With focus on neglected eye diseases, Opus buys two gene therapies from Iveric Bio
A seed-stage biotech founded by Luxturna’s inventor has acquired two gene therapy products from a biotech that just submitted an NDA.
Opus Genetics paid Iveric …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
